FABP4 Induces Vascular Smooth Muscle Cell Proliferation and Migration through a MAPK-Dependent Pathway

被引:56
作者
Girona, Josefa [1 ]
Rosales, Roser [1 ]
Plana, Nuria [1 ]
Saavedra, Paula [1 ]
Masana, Lluis [1 ]
Vallve, Joan-Carles [1 ]
机构
[1] Univ Rovira & Virgili, Sant Joan Univ Hosp, IISPV,Res Unit Lipids & Atherosclerosis, Spanish Biomed Res Ctr Diabet & Associated Metab, E-43201 Reus, Spain
关键词
ACID-BINDING PROTEIN; ADIPOSE-TISSUE DEPOTS; METABOLIC SYNDROME; PLASMA FATTY-ACID-BINDING-PROTEIN-4; CAROTID ATHEROSCLEROSIS; ENDOTHELIAL-CELLS; HEART-DISEASE; IN-VITRO; EXPRESSION; PATHOGENESIS;
D O I
10.1371/journal.pone.0081914
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: The migration and proliferation of vascular smooth muscle cells play crucial roles in the development of atherosclerotic lesions. This study examined the effects of fatty acid binding protein 4 (FABP4), an adipokine that is associated with cardiovascular risk, endothelial dysfunction and proinflammatory effects, on the migration and proliferation of human coronary artery smooth muscle cells (HCASMCs). Methods and Results: A DNA 5-bromo-2'-deoxy-uridine (BrdU) incorporation assay indicated that FABP4 significantly induced the dose-dependent proliferation of HCASMCs with a maximum stimulatory effect at 120 ng/ml (13% vs. unstimulated cells, p<0.05). An anti-FABP4 antibody (40 ng/ml) significantly inhibited the induced cell proliferation, demonstrating the specificity of the FABP4 proliferative effect. FABP4 significantly induced HCASMC migration in a dose-dependent manner with an initial effect at 60 ng/ml (12% vs. unstimulated cells, p<0.05). Time-course studies demonstrated that FABP4 significantly increased cell migration compared with unstimulated cells from 4 h (23% vs. 17%, p<0.05) to 12 h (74% vs. 59%, p<0.05). Pretreatment with LY-294002 (5 mu M) and PD98059 (10 mu M) blocked the FABP4-induced proliferation and migration of HCASMCs, suggesting the activation of a kinase pathway. On a molecular level, we observed an up-regulation of the MAPK pathway without activation of Akt. We found that FABP4 induced the active forms of the nuclear transcription factors c-jun and c-myc, which are regulated by MAPK cascades, and increased the expression of the downstream genes cyclin D1 and MMP2, CCL2, and fibulin 4 and 5, which are involved in cell cycle regulation and cell migration. Conclusions: These findings indicate a direct effect of FABP4 on the migration and proliferation of HCASMCs, suggesting a role for this adipokine in vascular remodelling. Taken together, these results demonstrate that the FABP4-induced DNA synthesis and cell migration are mediated primarily through a MAPK-dependent pathway that activates the transcription factors c-jun and c-myc in HCASMCs.
引用
收藏
页数:12
相关论文
共 37 条
[1]   Expression of fatty acid-binding protein 4/aP2 is correlated with plaque instability in carotid atherosclerosis [J].
Agardh, H. E. ;
Folkersen, L. ;
Ekstrand, J. ;
Marcus, D. ;
Swedenborg, J. ;
Hedin, U. ;
Gabrielsen, A. ;
Paulsson-Berne, G. .
JOURNAL OF INTERNAL MEDICINE, 2011, 269 (02) :200-210
[2]   Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells [J].
Aragones, Gemma ;
Saavedra, Paula ;
Heras, Mercedes ;
Cabre, Anna ;
Girona, Josefa ;
Masana, Lluis .
CARDIOVASCULAR DIABETOLOGY, 2012, 11
[3]   Small artery dilation and endothelial markers in cardiovascular risk patients [J].
Aragones, Gemma ;
Ferre, Raimon ;
Girona, Josefa ;
Plana, Nuria ;
Merino, Jordi ;
Heras, Mercedes ;
Masana, Lluis .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (01) :34-41
[4]   Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes [J].
Aragones, Gemma ;
Ferre, Raimon ;
Lazaro, Iolanda ;
Cabre, Anna ;
Plana, Nuria ;
Merino, Jordi ;
Heras, Mercedes ;
Girona, Josefa ;
Masana, Lluis .
ATHEROSCLEROSIS, 2010, 213 (01) :329-331
[5]   Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia [J].
Boord, JB ;
Maeda, K ;
Makowski, L ;
Babaev, VR ;
Fazio, S ;
Linton, MF ;
Hotamisligil, GS .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (10) :1686-1691
[6]   Cytoplasmic fatty acid-binding proteins: emerging roles in metabolism and atherosclerosis [J].
Boord, JB ;
Fazio, S ;
Linton, MF .
CURRENT OPINION IN LIPIDOLOGY, 2002, 13 (02) :141-147
[7]  
Cabre A, 2007, Atherosclerosis, V195, pe150
[8]   Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes [J].
Cabre, Anna ;
Lazaro, Iolanda ;
Girona, Josefa ;
Manzanares, Josep Maria ;
Marimon, Francesc ;
Plana, Nuria ;
Heras, Mercedes ;
Masana, Lluis .
JOURNAL OF LIPID RESEARCH, 2008, 49 (08) :1746-1751
[9]   Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria [J].
Cabre, Anna ;
Lazaro, Iolanda ;
Girona, Josefa ;
Manzanares, Josep M. ;
Marimon, Francesc ;
Plana, Nuria ;
Heras, Mercedes ;
Masana, Lluis .
CLINICAL CHEMISTRY, 2008, 54 (01) :181-187
[10]   FABP4 plasma levels are increased in familial combined hyperlipidemia [J].
Cabre, Anna ;
Lazaro, Iolanda ;
Cofan, Montserrat ;
Jarauta, Estibaliz ;
Plana, Nuria ;
Garcia-Otin, Angel L. ;
Ascaso, Juan F. ;
Ferre, Raimon ;
Civeira, Fernando ;
Ros, Emilio ;
Masana, Lluis .
JOURNAL OF LIPID RESEARCH, 2010, 51 (05) :1173-1178